Indications and uses
for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness
Driminate
- Manufacturer
- Avera McKennan Hospital
- Effective date
- 2016-01-12
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:45:14
Label at a glance#
ProductDriminate
Active ingredientDIMENHYDRINATE
Label structure9 sections
Dosage and administration
to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity adults and children 12 years of age and over: 1 to 2 tablets every 4-6 hours; not to exceed 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years of age: 1/2 to 1 tablet every 6-8 hours; not to exceed 3 tablets in 24 hours, or as directed by a doctor children 2 to under 6 years of age: ...
Storage and handling
store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF) protect from moisture see end flap for expiration date and lot number
Contacts and useful links#
Label contents#
Full prescribing information#
Active ingredient (in each tablet)
Dimenhydrinate 50 mg
Purpose
Antiemetic
Uses
for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness
Warnings
Do not use
for children under 2 years of age unless directed by a doctor.
Ask a doctor before use if you have
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
- difficulty in urination due to an enlargement of the prostate gland
Ask a doctor or pharmacist before use if you are
taking sedatives or tranquilizers.
When using this product
- marked drowsiness may occur
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase drowsiness
- use caution when driving a motor vehicle or operating machinery
If pregnant or breast-feeding,
ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Directions
- to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity
- adults and children 12 years of age and over: 1 to 2 tablets every 4-6 hours; not to exceed 8 tablets in 24 hours, or as directed by a doctor
- children 6 to under 12 years of age: 1/2 to 1 tablet every 6-8 hours; not to exceed 3 tablets in 24 hours, or as directed by a doctor
- children 2 to under 6 years of age: 1/2 tablet every 6-8 hours; not to exceed 1 1/2 tablets in 24 hours, or as directed by a doctor
Other information
- store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
- protect from moisture
- see end flap for expiration date and lot number
Inactive ingredients
croscarmellose sodium, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silica gel, stearic acid
Questions or comments?
(800) 616-2471
Principal Display Panel
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| DIPHENHYDRAMINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69189-2051-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0da4-f424-e053-dadaa90a57ce | e2737ab2-b6d6-4da1-a8e1-3d2b261ec1b5 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69189-2051-1 | Driminate | 1 in 1 DOSE PACK | TABLET | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69189-2051 | DRIMINATE (DIMENHYDRINATE) TABLET [AVERA MCKENNAN HOSPITAL] | 1 | Legacy NDC, 1 package rows | 20160302_e2737ab2-b6d6-4da1-a8e1-3d2b261ec1b5.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-2051-12 | EA - Each | 0904-2051 | 4989e796-050f-448b-b3e0-1c0a4596af05 | 1 | 2012-07-24 |
| 0904-2051-59 | EA - Each | 0904-2051 | d4a56ff5-028d-4d12-a116-d74cf39917c5 | 1 | 2013-08-02 |
Products#
Every source-derived product name is available through these pages.
- Driminate
- Dimenhydrinate
- DIPHENHYDRAMINE
- CROSCARMELLOSE SODIUM
- CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
- MAGNESIUM STEARATE
- CELLULOSE, MICROCRYSTALLINE
- STEARIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69189-2051 | 69189-2051-1 |
| 0904-2051 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMENHYDRINATE | JB937PER5C | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | L11K75P92J | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Driminate | DIMENHYDRINATE | Major Pharmaceuticals | d2967f78-41ee-4c30-8b47-0757df9f3d91 | 2026-06-10 | Warnings | 0904-2051 |
| 8c087f7e-dc26-40d7-96ab-368c9f5f942c | e2737ab2-b6d6-4da1-a8e1-3d2b261ec1b5 | 2016-01-12 | Warnings | 8c087f7e-dc26-40d7-96ab-368c9f5f942c e2737ab2-b6d6-4da1-a8e1-3d2b261ec1b5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.